Skip to main content

Animations

MJFF Publications

5431 - 5440 of 6324 Results
Title
Year
  • Year
  • 2024
  • 2021
  • 2022
  • 2022
  • 2021
  • 2025
  • 2021
  • 2018
  • 2016
  • 2021
  • Summary Details
    OPEN
    Title: Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00751-w
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01256-w
    Citation Count: 11
  • Summary Details
    OPEN
    Title: SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202111018
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's disease
    Journal Name: Neuropsychologia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in Tissue
    Journal Name: The Journal of Physical Chemistry B
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jpcb.1c07762
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Genetic Modifiers of Parkinson's Disease: A Case–Control Study
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.70176
    Citation Count: 0
  • Summary Details
    OPEN
    Title: T lymphocyte senescence is attenuated in Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-021-02287-9
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Clinical deep brain stimulation strategies for orientation-selective pathway activation
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/1741-2552/aad978
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embj.2020105531
    Citation Count: 23
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.